Stanford University at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Stanford University brings 2 presentations to ESGCT 2026 in Hamburg. Its program covers engineering CAR-T cells for stronger and longer-lasting activity. It includes generating CAR-T cells inside the body with a targeted lentivirus plus a supporting cytokine, and organoid models that trace how reprogrammed brain immune cells affect CAR-T performance.
| Organization | ESGCT 2026 Attendance |
|---|---|
Stanford University Stanford, CA | |
California research university with groups working on CAR-T cell engineering and gene editing of blood stem cells. | Talk Tue Oct 27 6:00pm–7:30pm Codelivery of IL9 to enhance engraftment and potency of in vivo engineered CAR-T cells generated via CD3-targeting lentivirus. Cell therapies and CAR-TVectors and delivery (AAV, lentiviral, LNP) Chair Wed Oct 28 11:00am–12:30pm SESSION 4d: Metabolic diseases II In collaboration with ASGCT and AGCTS Rare and inherited disease Talk Thu Oct 29 5:30pm–6:00pm Tumor-Immune Organoids and Immunocompetent Models Identify Microglial Reprogramming as a Novel Mechanism of cJUN-Enhanced CAR-T Function Cell therapies and CAR-TCancer gene and cell therapy |
Instantly find 20 buyers from Stanford University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction